blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2137295

EP2137295 - USE OF A COMPOSITION AND METHOD FOR ENABLING PROLIFERATION OF PLURIPOTENT STEM CELLS [Right-click to bookmark this link]
Former [2010/01]COMPOSITION AND METHOD FOR ENABLING PROLIFERATION OF PLURIPOTENT STEM CELLS
[2017/39]
StatusNo opposition filed within time limit
Status updated on  22.02.2019
Database last updated on 01.01.2025
FormerThe patent has been granted
Status updated on  16.03.2018
FormerGrant of patent is intended
Status updated on  01.11.2017
FormerExamination is in progress
Status updated on  23.11.2016
Most recent event   Tooltip09.07.2021Lapse of the patent in a contracting state
New state(s): HU
published on 11.08.2021  [2021/32]
Applicant(s)For all designated states
Tryggvason, Karl
Lokevägen 8 A
182 61 Djursholm / SE
For all designated states
Domogatskaya, Anna
Centralvägen 8A
14462 Rönninge / SE
For all designated states
Rodin, Sergey
Sveavägen 164, Apt. J12
11346 Stockholm / SE
[2010/01]
Inventor(s)01 / see applicant
...
 [2010/01]
Representative(s)Novitas Patent AB
P.O. Box 55557
102 04 Stockholm / SE
[N/P]
Former [2018/16]Kador & Partner
Corneliusstraße 15
80469 München / DE
Former [2010/01]Kador & Partner
Corneliusstrasse 15
80469 München / DE
Application number, filing date08709835.604.01.2008
[2010/01]
WO2008IB00370
Priority number, dateUS20070883406P04.01.2007         Original published format: US 883406 P
[2010/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008084401
Date:17.07.2008
Language:EN
[2008/29]
Type: A2 Application without search report 
No.:EP2137295
Date:30.12.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 17.07.2008 takes the place of the publication of the European patent application.
[2009/53]
Type: B1 Patent specification 
No.:EP2137295
Date:18.04.2018
Language:EN
[2018/16]
Search report(s)International search report - published on:EP19.02.2009
ClassificationIPC:C12N5/0735
[2017/39]
CPC:
C12N5/0606 (EP,US); C12N5/00 (KR); C12N5/06 (KR);
C12N5/0602 (KR); C12N2533/52 (EP,US)
Former IPC [2010/01]C12N5/06
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2018/16]
Former [2010/01]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ZUSAMMENSETZUNG UND VERFAHREN FÜR DIE VERMEHRUNG PLURIPOTENTER STAMMZELLEN[2010/01]
English:USE OF A COMPOSITION AND METHOD FOR ENABLING PROLIFERATION OF PLURIPOTENT STEM CELLS[2017/39]
French:COMPOSITION ET PROCÉDÉ POUR PERMETTRE LA PROLIFÉRATION DE CELLULES SOUCHES PLURIPOTENTES[2010/01]
Former [2010/01]COMPOSITION AND METHOD FOR ENABLING PROLIFERATION OF PLURIPOTENT STEM CELLS
Entry into regional phase31.07.2009National basic fee paid 
31.07.2009Designation fee(s) paid 
31.07.2009Examination fee paid 
Examination procedure28.07.2008Request for preliminary examination filed
International Preliminary Examining Authority: EP
31.07.2009Examination requested  [2009/53]
21.07.2010Despatch of a communication from the examining division (Time limit: M06)
24.01.2011Reply to a communication from the examining division
10.10.2012Despatch of a communication from the examining division (Time limit: M06)
19.03.2013Reply to a communication from the examining division
11.06.2014Despatch of a communication from the examining division (Time limit: M04)
15.10.2014Reply to a communication from the examining division
13.05.2016Cancellation of oral proceeding that was planned for 02.06.2016
19.05.2016Despatch of a communication from the examining division (Time limit: M06)
02.06.2016Date of oral proceedings (cancelled)
21.11.2016Reply to a communication from the examining division
02.11.2017Communication of intention to grant the patent
06.03.2018Fee for grant paid
06.03.2018Fee for publishing/printing paid
06.03.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.07.2010
Opposition(s)21.01.2019No opposition filed within time limit [2019/13]
Fees paidRenewal fee
07.01.2010Renewal fee patent year 03
06.01.2011Renewal fee patent year 04
09.01.2012Renewal fee patent year 05
08.01.2013Renewal fee patent year 06
08.01.2014Renewal fee patent year 07
08.01.2015Renewal fee patent year 08
08.01.2016Renewal fee patent year 09
08.12.2016Renewal fee patent year 10
08.01.2018Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.01.2008
AT18.04.2018
CY18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
IT18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SI18.04.2018
SK18.04.2018
TR18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
IS18.08.2018
PT20.08.2018
IE04.01.2019
LU04.01.2019
MT04.01.2019
[2021/32]
Former [2021/31]AT18.04.2018
CY18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
IT18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SI18.04.2018
SK18.04.2018
TR18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
IS18.08.2018
PT20.08.2018
IE04.01.2019
LU04.01.2019
MT04.01.2019
Former [2021/26]AT18.04.2018
CY18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
IT18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SI18.04.2018
SK18.04.2018
TR18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
IE04.01.2019
LU04.01.2019
MT04.01.2019
Former [2020/29]AT18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
IT18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SI18.04.2018
SK18.04.2018
TR18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
IE04.01.2019
LU04.01.2019
MT04.01.2019
Former [2020/16]AT18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
IT18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SI18.04.2018
SK18.04.2018
TR18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
IE04.01.2019
LU04.01.2019
Former [2020/09]AT18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
IT18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SI18.04.2018
SK18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
IE04.01.2019
LU04.01.2019
Former [2019/44]AT18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
IT18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SI18.04.2018
SK18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
LU04.01.2019
Former [2019/40]AT18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
IT18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SI18.04.2018
SK18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
Former [2019/26]AT18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
IT18.04.2018
LT18.04.2018
LV18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SI18.04.2018
SK18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
Former [2019/12]AT18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
IT18.04.2018
LT18.04.2018
LV18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SK18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
Former [2019/10]AT18.04.2018
CZ18.04.2018
EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
NL18.04.2018
PL18.04.2018
RO18.04.2018
SK18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
Former [2019/09]EE18.04.2018
ES18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
NL18.04.2018
PL18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
Former [2019/03]ES18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
NL18.04.2018
PL18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
PT20.08.2018
Former [2018/52]ES18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
NL18.04.2018
PL18.04.2018
BG18.07.2018
NO18.07.2018
GR19.07.2018
Former [2018/51]ES18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
NL18.04.2018
PL18.04.2018
BG18.07.2018
NO18.07.2018
Former [2018/50]ES18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
NL18.04.2018
PL18.04.2018
BG18.07.2018
NO18.07.2018
Former [2018/47]ES18.04.2018
FI18.04.2018
LT18.04.2018
NL18.04.2018
NO18.07.2018
Former [2018/43]NL18.04.2018
Cited inInternational search[A]WO2006017370  (GERON CORP [US], et al) [A] 1-20 * the whole document * * figures 9,10; examples 1,2 *;
 [X]  - HASHIMOTO JUNKO ET AL, "Regulation of proliferation and chondrogenic differentiation of human mesenchymal stem cells by laminin-5 (laminin-332)", STEM CELLS (MIAMISBURG), (200611), vol. 24, no. 11, ISSN 1066-5099, pages 2346 - 2354, XP002506193 [X] 1-20 * the whole document * * figures 1,2 *

DOI:   http://dx.doi.org/10.1634/STEMCELLS.2005-0605
 [A]  - MALLON ET AL, "Toward xeno-free culture of human embryonic stem cells", INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY, EXETER, GB, (20060101), vol. 38, no. 7, ISSN 1357-2725, pages 1063 - 1075, XP005362917 [A] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.biocel.2005.12.014
 [T]  - DOMOGATSKAYA ANNA ET AL, "Laminin-511 but not -332, -111, or -411 enables mouse embryonic stem cell self-renewal in vitro.", STEM CELLS (DAYTON, OHIO) NOV 2008, (200811), vol. 26, no. 11, ISSN 1549-4918, pages 2800 - 2809, XP009109423 [T] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1634/stemcells.2007-0389
ExaminationWO03046141
    - M. DOI, "Recombinant Human Laminin-10 (alpha 5beta 1gamma 1). PRODUCTION, PURIFICATION, AND MIGRATION-PROMOTING ACTIVITY ON VASCULAR ENDOTHELIAL CELLS", JOURNAL OF BIOLOGICAL CHEMISTRY, (20020405), vol. 277, no. 15, doi:10.1074/jbc.M111228200, ISSN 0021-9258, pages 12741 - 12748, XP055022474

DOI:   http://dx.doi.org/10.1074/jbc.M111228200
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.